Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. is a clinical-stage oncology company developing diffusing alpha-emitters radiation therapy (Alpha-DaRT), a targeted approach to treating solid tumors. The technology delivers alpha radiation directly to cancer tissue, with the company currently evaluating its therapeutic potential across multiple cancer types including skin, oral, pancreatic, prostate, lung, liver, and breast cancers. The company also maintains preclinical and pending clinical programs for brain and other cancers.

The company operates primarily as a research and development organization with no significant commercial revenue at this stage. Alpha Tau Medical maintains its headquarters in Jerusalem, Israel, and employs approximately 125 full-time staff members. The organization is listed on Nasdaq and incorporated under Israeli law, providing it access to capital markets while remaining based in the Israeli biotech sector.